ResMed swings to profit, sleep device sales rise

NEW YORK, May 1 (Reuters) - Respiratory equipment maker ResMed Inc (RMD.N) posted a fiscal third-quarter profit on lower expenses and higher sales of its devices for sleep breathing disorders, the company said on Thursday.

ResMed said it earned $29.7 million, or 38 cents per share. That compared with a loss of $15.4 million, or 20 cents per share, in the year-ago period, when ResMed took a big charge for its voluntary withdrawal of 300,000 flow generators used to treat sleep apnea. (Reporting by Ransdell Pierson; Editing by Andre Grenon)